What We're Reading: Page
Industry reads hand-picked by our editors
Sep 29, 2023
Sep 28, 2023
-
Reuters
Biden plans $100 million drive to combat drug-resistant ‘superbugs’
-
The New England Journal of Medicine
Death of a Patient after High-Dose Gene Therapy
-
NPR
Japanese scientists pioneer potential breakthrough for infertility
Sep 27, 2023
-
Fierce Biotech
Gilead ends phase 3 leukemia trial early after data disappoint
-
Bloomberg
BioNTech Is Revising Plans for African Vaccine Factory Network
-
Stat
After a drawn out lobbying fight, ARPA-H chooses its headquarters
-
Science
Malaria cases could ebb in an even hotter world. But other diseases will get worse
Sep 26, 2023
-
Reuters
Ionis’ metabolic disorder drug lowers high levels of a type of fat in study
-
FirstWord Pharma
Takeda partners with AcuraStem on ALS drug development
-
Financial Times
Covid antiviral drug linked to ‘transmissible’ mutations, research finds
-
The Wall Street Journal
The Band of Debunkers Busting Bad Scientists
Sep 25, 2023
Sep 22, 2023
Sep 21, 2023
-
STAT News
They carry a gene for ALS but aren’t sick. What does medical research owe them?
-
Bloomberg Law
Drugmakers Aren’t Waiting Around for Details on Medicare Tax
-
Reuters
India’s Glenmark to sell majority stake in life sciences unit for $680 million
-
MIT Technology Review
DeepMind is using AI to pinpoint the causes of genetic disease
Previous
